Market Place
Sourcing Support
SK Eyes Xcopri Expansion with Phase 3 Win in New Seizure Type
17 Sep 2025 //
FIERCE PHARMA
Sk Bioscience Submits IND for Phase 1/2 Trial of Flu Vaccine
17 Jul 2025 //
PR NEWSWIRE
SK Bio applies for IND for domestic phase 3 clinical trial
29 Oct 2024 //
PRESS RELEASE
SK begins `globalization` push, paying $244M for majority stake in IDT Biologika
27 Jun 2024 //
FIERCE PHARMA
SK bioscience Breaks Ground on Manufacturing Facility Expansion
07 Mar 2024 //
PR NEWSWIRE
SK Bioscience suspends production of COVID-19 vaccine `Sky Covione`
24 Nov 2022 //
HEALTH ET
SK Bioscience`s Covid-19 vaccine losing against multinationals’ bivalent vaccine
10 Nov 2022 //
KOREABIOMED
SK bioscience unveils strategy aimed at global market expansion
03 Nov 2022 //
FIERCEPHARMA
SK bioscience and CEPI enter mRNA vaccine development deal
27 Oct 2022 //
PHARMACEUTICAL-TECHNOLOGY
CEPI and SK bioscience partner to advance mRNA vaccine technology
26 Oct 2022 //
INDIANPHARMAPOST
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
25 Oct 2022 //
PRNEWSWIRE
CEPI teams up with Korean vaccine maker in $140M pact
25 Oct 2022 //
ENDPTS
SK bioscience Appoints New Executives towards Global Business Growth
21 Oct 2022 //
PRNEWSWIRE
Novavax and SK bioscience File a Post Approval Change Application in South Korea
10 Oct 2022 //
PRESS RELEASE
Korea`s 1st homegrown COVID-19 vaccine maker underlines global partnership
03 Oct 2022 //
ASIANEWS
SK Bioscience applies for SKYCovione`s WHO emergency use listing
09 Sep 2022 //
KOREAHERALD
SK bioscience begins first shipment of Korean Covid-19 vaccine, SKYCovione
03 Sep 2022 //
PHARMABIZ
SK Bioscience`s SKYCovione proven effective against omicron virus subvariants
02 Sep 2022 //
INFORMA
World Health Organization Approves SK bioscience as a Supplier of Novavax Nuvaxovid™ COVID-19 Vaccine
02 Sep 2022 //
PRESS RELEASE
Novavax’s Covid-19 vaccine gets approval in South Korea for adolescents
15 Aug 2022 //
PHARMACEUTICAL-TECHNOLOGY
SK bioscience Covid-19 vaccine active against BA.1 variant in Phase I/II trial
14 Jul 2022 //
CLINICALTRIALSARENA
EMA Approves SK bioscience as a Supplier of Novavax Nuvaxovid
07 Jul 2022 //
PRESS RELEASE
S.Korea approves first domestically developed COVID vaccine
28 Jun 2022 //
REUTERS
GSK and SK bioscience`s COVID vaccine submitted for S.Korea approval
29 Apr 2022 //
REUTERS
SK advances Gates-backed COVID-19 antiviral spray toward clinic
19 Apr 2022 //
FIERCEPHARMA
South Korea Ministry of Food and Drug Safety approves Novavax COVID-19 vaccine
13 Jan 2022 //
PHARMAFILE
SK takes out stake in cell & gene therapy CDMO with plans for major hiring spree
11 Jan 2022 //
ENDPTS
S. Korean drug firms rush to develop vaccines effective against omicron
18 Dec 2021 //
KOREAHERALD
South Korean drugmaker SK looks to take over Philly CDMO`s operations
18 Nov 2021 //
ENDPTS
Novavax and SK bioscience submit BLA for Covid-19 vaccine in South Korea
15 Nov 2021 //
PHARMACEUTICAL-TECHNOLOGY
SK bioscience & CEPI Extend Agreement, COVID-19 Vaccine by the End of 2022
06 Oct 2021 //
YNA
SK Bioscience likely to secure vaccine supply deal from COVAX next year: report
15 Sep 2021 //
KOREAHERALD
COVID-19 fuels HK-Shenzhen cooperation in biotech
31 Aug 2021 //
EJINSIGHT
GSK hopes for vaccine success as new shot enters late-stage trial
31 Aug 2021 //
FINANCIAL TIMES
SK bioscience-GSK Covid-19 vaccine candidate enters Phase III trial
31 Aug 2021 //
CLINICAL TRAIL ARENA
South Korean vaccine vs AstraZeneca shot in PIII; ACIP approves PFE/BNT vaccine
31 Aug 2021 //
ENDPTS
SK bioscience moves into phase 3 trials for its COVID-19 vaccine
12 Aug 2021 //
PM LIVE
S. Korea approves Phase III trial of SK Bioscience`s COVID-19 vaccine
09 Aug 2021 //
REUTERS
S.Korea pledges nearly $2 bln to become major COVID-19 vaccine producer
06 Aug 2021 //
REUTERS
S.Korea`s SK bioscience to invest $132 mln to boost vaccine production
21 Jun 2021 //
REUTERS
South Korean vaccine maker pumps up its production capacity as Covid-19
21 Jun 2021 //
ENDPTS
CEPI and SK bioscience expand partnership to develop vaccine against COVID-19
11 Mar 2021 //
CEPI
With IPO coming, SK earmarks $450M for manufacturing expansion
25 Feb 2021 //
FIERCE PHARMA
With Novavax vaccine deal under its belt, SK Bioscience plots out March IPO
25 Feb 2021 //
ENDPTS
Novavax, SK Bioscience expand Covid-19 vaccine manufacturing deal
16 Feb 2021 //
PHARMACEUTICAL-TECHNOLOGY
SK Bioscience’s COVID-19 vaccine to be used with GSK adjuvant
04 Feb 2021 //
KOREANHERALD
CEPI and SK Bioscience to develop next generation COVID-19 vaccine
14 Dec 2020 //
BIOSPECTRUMASIA
Novavax, SK bioscience Collaborate for COVID-19 Vax Candidate
12 Aug 2020 //
CONTRACTPHARMA
South Korea`s SK Bioscience in deal with AstraZeneca on vaccine
21 Jul 2020 //
REUTERS
